Your browser doesn't support javascript.
loading
Donor genetic burden for cerebrovascular risk and kidney transplant outcome.
Collins, Kane E; Gilbert, Edmund; Mauduit, Vincent; Benson, Katherine A; Elhassan, Elhussein A E; O'Seaghdha, Conall; Hill, Claire; McKnight, Amy Jayne; Maxwell, Alexander P; van der Most, Peter J; de Borst, Martin H; Guan, Weihua; Jacobson, Pamala A; Israni, Ajay K; Keating, Brendan J; Lord, Graham M; Markkinen, Salla; Helanterä, Ilkka; Hyvärinen, Kati; Partanen, Jukka; Madden, Stephen F; Limou, Sophie; Cavalleri, Gianpiero L; Conlon, Peter J.
Afiliação
  • Collins KE; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Gilbert E; The Science Foundation Ireland FutureNeuro Centre of Excellence, Dublin, Ireland.
  • Mauduit V; SFI Centre for Research Training in Genomics Data Science, University of Galway, Galway, Ireland.
  • Benson KA; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Elhassan EAE; The Science Foundation Ireland FutureNeuro Centre of Excellence, Dublin, Ireland.
  • O'Seaghdha C; Center for Research in Transplantation and Translational Immunology, UMR1064, Nantes University, Ecole Centrale Nantes, INSERM, Nantes, France.
  • Hill C; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • McKnight AJ; The Science Foundation Ireland FutureNeuro Centre of Excellence, Dublin, Ireland.
  • Maxwell AP; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • van der Most PJ; Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • de Borst MH; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • Guan W; Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Jacobson PA; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
  • Israni AK; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
  • Keating BJ; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
  • Lord GM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Markkinen S; Department of Internal Medicine, Divison of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Helanterä I; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Hyvärinen K; College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
  • Partanen J; College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
  • Madden SF; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Limou S; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Cavalleri GL; Finnish Red Cross Blood Service, Research and Development, Biomedicum 1, Helsinki, Finland.
  • Conlon PJ; Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland.
J Nephrol ; 2024 May 29.
Article em En | MEDLINE | ID: mdl-38809363
ABSTRACT
BACKGROUND AND

HYPOTHESIS:

Kidney grafts from donors who died of stroke and related traits have worse outcomes relative to grafts from both living donors and those who died of other causes. We hypothesise that deceased donors, particularly those who died of stroke, have elevated polygenic burden for cerebrovascular traits. We further hypothesise that this donor polygenic burden is associated with inferior graft outcomes in the recipient.

METHODS:

Using a dataset of 6666 deceased and living kidney donors from seven different European ancestry transplant cohorts, we investigated the role of polygenic burden for cerebrovascular traits (hypertension, stroke, and intracranial aneurysm (IA)) on donor age of death and recipient graft outcomes.

RESULTS:

We found that kidney donors who died of stroke had elevated intracranial aneurysm and hypertension polygenic risk scores, compared to healthy controls and living donors. This burden was associated with age of death among donors who died of stroke. Increased donor polygenic risk for hypertension was associated with reduced long term graft survival (HR 1.44, 95% CI [1.07, 1.93]) and increased burden for hypertension, and intracranial aneurysm was associated with reduced recipient estimated glomerular filtration rate (eGFR) at 1 year.

CONCLUSIONS:

Collectively, the results presented here demonstrate the impact of inherited factors associated with donors' death on long-term graft function.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article